Diabetes, Digestive, And Kidney Diseases Extramural Research federal funding in Connecticut

Connecticut × 93.847 is diabetes-kidney research, not a patient census

This page pairs CFDA 93.847, DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH, with Connecticut place of performance. Diabetes, Digestive, And Kidney Diseases Extramural Research, as named on the catalog line, is the listing on one side of the join; Connecticut (CT) is the geography tag on the other. SpendingVault sums tagged obligations: $472,317,143.46 on 200 awards. The extract does not list trial enrollments, New Haven shares, or a diabetes-versus-kidney split. Treat the pair as a catalog intersection, not a ranking of which state needs the program more, and not a claim that 200 awards equal that many Connecticut research campuses. Connecticut (CT) excludes New York, Massachusetts, and Rhode Island. Yale folklore is not a campus extract. Place of performance is CT statewide.

Other listings — allergy-and-infectious-disease research on 93.855 or other 93-series research rows — sit outside $472,317,143.46 unless they also carry 93.847. Mixing Diabetes research with those rows would invent a combined figure the packet never computed. Correlation between this obligation sum and obesity rates is not causation. Those statistics are not in the packet. Place of performance as Connecticut locates the tagged awards; it does not deposit $472,317,143.46 in the state treasury, and it does not prove every dollar stayed inside Connecticut after subawards. medical-school folklore is not a published cut of this extract.

200 awards behind the Connecticut 93.847 total

Award count is a row count of assistance awards, including possible continuations and modifications. It is not a census of Connecticut diabetes patients or unique investigators. a research file of two hundred award rows, not a formula lump. Mean obligation is about $2.36 million if $472,317,143.46 were divided evenly across two hundred lines — a mechanical ratio, not a typical payment published by the agency.

The listing names diabetes, digestive, and kidney diseases together. This packet does not split $472,317,143.46 among those three disease groups. Two hundred awards stay on 93.847 × CT. The 93.855 allergy cell is a different CFDA. Two hundred awards are scannable on the overlay. This page will not invent recipient names. Open Diabetes, Digestive, And Kidney Diseases Extramural Research in Connecticut for the stored table. Do not convert 200 into a map of Connecticut research campuses. The $472,317,143.46 total remains an obligation rollup on tagged awards.

Extramural obligations are not Connecticut lab cash already spent

Assistance awards often obligate to a state or recipient and draw as activities proceed. The $472,317,143.46 headline is the obligation sum, not extramural draws already posted, and not a Treasury outlay total. No fiscal year is attached. An agency table dated to a particular year is not automatically this join unless it uses CFDA 93.847, Connecticut geography, and the obligation metric.

The listing title is Diabetes, Digestive, And Kidney Diseases Extramural Research. This extract does not split activity types inside $472,317,143.46. Those cuts would require award documentation beyond the packet facts. The listing names diabetes, digestive, and kidney diseases together. This packet does not split $472,317,143.46 among those three disease groups. Two hundred awards stay on 93.847 × CT. The 93.855 allergy cell is a different CFDA.

What the Connecticut diabetes-research table omits

The extract has no trial enrollments, New Haven shares, or a diabetes-versus-kidney split. Facts remain $472,317,143.46, two hundred awards, CFDA 93.847, and Connecticut. This page will not invent a ranking against other states' 93.847 joins. Connecticut (CT) excludes New York, Massachusetts, and Rhode Island. Yale folklore is not a campus extract. Place of performance is CT statewide.

Connecticut federal spending and Connecticut programs place 93.847 among other listings. CFDA 93.847 is the national catalog line. All spending ties indexes other CFDA × state pairs. Mixing those shelves would invent a share of federal spending the packet never computed. The $472,317,143.46 figure is the tagged pair only.

Where the 93.847 × Connecticut overlay lives

Start with Diabetes, Digestive, And Kidney Diseases Extramural Research in Connecticut for the table behind $472,317,143.46. CFDA 93.847 is the nationwide listing. Connecticut federal spending and Connecticut programs give state context. All spending ties is the shelf for other program-by-state joins on the same obligation metric. Two hundred awards totaling $472,317,143.46 remain a research file of two hundred award rows, not a formula lump, not a census of Connecticut diabetes patients or unique investigators. Trial enrollments, New Haven shares, or a diabetes-versus-kidney split are not in this packet. Outlays, remaining balances, and fiscal-year splits are omitted because they are not in the facts. Use the overlay for named award lines as USAspending stored them.

SpendingVault's extract for this join publishes two quantities: $472,317,143.46 in obligations and two hundred awards. Everything else on this page is a description of what those two numbers are and are not. CFDA 93.847 is the catalog code; Connecticut is the place-of-performance state. The page does not add a fiscal year, a recipient roster, or a share of Connecticut spending, because those figures are not in the packet. If a dashboard elsewhere shows a different Diabetes research total, it may be using outlays, a different year, or a different geography. Those alternatives are not this join unless they use the same CFDA, the same state field, and the same obligation metric. USAspending.gov remains the originating system.

Questions

How much Diabetes research is obligated in Connecticut?

USAspending.gov shows $472,317,143.46 in obligations for CFDA 93.847 with Connecticut as place of performance, across two hundred awards. The sum is a commitment total on assistance awards, not outlays and not the state's entire federal-spending total. Other listings are outside this join unless they also carry 93.847.

Do 200 awards mean 200 Connecticut diabetes studies?

No. Award count is a row count of assistance awards and can include continuations. It is not a census of Connecticut diabetes patients or unique investigators. The packet does not name recipients. See Diabetes, Digestive, And Kidney Diseases Extramural Research in Connecticut for named lines as USAspending stored them. Unique Connecticut research campuses are unpublished.

Does this total include Connecticut allergy research on 93.855?

No. The join is CFDA 93.847 crossed with Connecticut place of performance. Related programs on other CFDA numbers are not inside $472,317,143.46 unless the award also carries 93.847. allergy-and-infectious-disease research on 93.855 or other 93-series research rows. Mixing those rows would invent a combined figure the packet never computed.

Is the Diabetes research total already paid in Connecticut?

Not on this metric. Obligations are recorded commitments on assistance awards. Outlays are payments from the Treasury. The $472,317,143.46 headline is the obligation rollup in SpendingVault's extract. Completed activity and remaining balances are not published in this packet.